News about Drug Discovery & Development

Aptar Pharma launches first metal-free nasal spray pump

Specifically designed for recyclability, APF Futurity is Aptar Pharma’s first highly recyclable nasal spray pump

Drug Discovery & Development | 31/01/2023 | By Sudeep Soparkar |  820

Sun Pharma Launches SEZABY in US to treat neonatal seizures

This is the first and only FDA Approved product in US to treat neonatal seizures

Drug Discovery & Development | 27/01/2023 | By Sudeep Soparkar |  1017

ENTOD Pharma's state-of-the-art R&D facility opens in Navi Mumbai

The brand new additional R&D facility in Navi Mumbai has been designed with state-of-the-art equipment and the latest analytical & formulation research tools

Drug Discovery & Development | 27/01/2023 | By Sudeep Soparkar |  792

Marksans Pharma announces UK MHRA approval for Fluoxetine 20mg/5ml oral solution

The product will be manufactured at the plant of Bell, Sons & Co, UK

Drug Discovery & Development | 24/01/2023 | By Sudeep Soparkar |  557

Eurofins CDMO Alphora expands API development labs

The 56,000-square foot building is the new home of Eurofins CDMO Alphora’s API process R&D activity, solid-state R&D activity and its analytical services team

Drug Discovery & Development | 17/01/2023 | By Sudeep Soparkar |  724

AstraZeneca partners with Australia-based LBT Innovations for new pharma product line

AstraZeneca will fund the development of the APAS Pharma analysis module and validate the final product for their processes
<br />

Drug Discovery & Development | 12/01/2023 | By Sudeep Soparkar |  689

Glenmark Pharma launches Bumetanide Injection in single and multi-dose vials

The product is the generic version of Bumex 1 Injection, 0.25 mg/mL, of Validus Pharmaceuticals

Drug Discovery & Development | 11/01/2023 | By Sudeep Soparkar |  714

Zydus launches Topiramate extended-release capsules

Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the US
<br />

Drug Discovery & Development | 07/01/2023 | By Sudeep Soparkar |  673

Asymchem opens R&D site near Boston, Massachusetts

The new Boston site is focussed on providing early-stage R&D services including chemical process development, pre-formulation study and formulation development
<br />

Drug Discovery & Development | 20/12/2022 | By Sudeep Soparkar |  728

Freudenberg Medical unveils HelixFlex at CPhI & PMEC India

TPE tubing is ideal for pharmaceutical bioprocessing applications

Drug Discovery & Development | 30/11/2022 | By Sudeep Soparkar |  696